Identification and characterization of host proteins involved in the alphavirus exit pathway
甲病毒退出途径中宿主蛋白的鉴定和表征
基本信息
- 批准号:10495264
- 负责人:
- 金额:$ 21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlphavirusAntiviral AgentsAntiviral TherapyArthritogenicBioinformaticsBiologicalBiological AssayBiotinBiotinylationCapsidCapsid ProteinsCell membraneCellsChemicalsChikungunya virusCollaborationsCrosslinkerCytoplasmDataDiseaseEnzymesEvaluationFlow CytometryGenomeGrantHumanInfectionIntegral Membrane ProteinIntegration Host FactorsKnock-inKnock-outLabelLigaseLipid BilayersLocationMass Spectrum AnalysisMayaro virusMediatingMedicalMembraneMembrane FusionMethodsNatureNucleocapsidPathway interactionsPeptidesPermeabilityPlasma CellsPrimary InfectionProcessProductionProtein AnalysisProtein BiosynthesisProteinsProteomeProteomicsPublishingRNARNA VirusesReporterRetrievalRiversRoleRoss river virusSamplingSemliki forest virusSindbis VirusSiteSmall Interfering RNAStatistical Data InterpretationStreptavidinStructural ProteinStructureSystemTestingTrypsinVaccinesVenezuelan Equine Encephalitis VirusVesicular stomatitis Indiana virusViralVirionVirusVirus-like particlebasebiodefensechikungunyacrosslinkemerging human pathogenhuman pathogenmagnetic beadsmutantnovelnovel strategiesoverexpressionparticleprotein crosslinksecondary infectionuptakeviral resistancevirus envelope
项目摘要
Alphaviruses include important and emerging human pathogens such as encephalitic viruses and the
arthritogenic Chikungunya, Ross River, and Mayaro viruses. There are currently no licensed antiviral therapies
or vaccines, and new approaches and information are needed to develop antiviral strategies.
Alphaviruses are small enveloped RNA viruses with highly ordered structures. The nucleocapsid core is
composed of the plus-sense RNA genome enclosed in a capsid protein shell, and is surrounded by the virus
envelope, a membrane containing an organized lattice of the E2 and E1 transmembrane proteins. There is
increasing understanding of alphavirus structure, entry, and replication, and the functions of host proteins in
these processes. In contrast, much less is known about the roles of host proteins in the late steps of the
alphavirus exit pathway, including nucleocapsid assembly/transport and virus budding at the plasma
membrane. This grant aims to use proteomics to identify host proteins that interact with the virus capsid
protein, and determine their roles in virus exit. Such an approach has been difficult because capsid protein is
highly basic in nature and interacts non-specifically with host proteins during retrieval. Tagging the capsid
protein with relatively large tags such as fluorescent proteins leads to major distortions in the organized capsid
lattice and the viral particle. Instead, we have developed an approach based on insertion of a 13 residue biotin
acceptor peptide into a permissive site on capsid. Infection of cells expressing the BirA biotinylation enzyme
leads to efficient biotin labeling of capsid and nucleocapsid in cells and virus particles. Our preliminary data
have established efficient and specific retrieval of biotinylated capsid using Streptavidin magnetic beads. We
will use this system to identify capsid-associated cellular proteins in infected cells. The specific aims are:
1. Use a novel biotin-based capsid pull-down strategy to identify host proteins involved in
alphavirus exit. We will use our optimized methods to perform chemical crosslinking, specific biotin-based
retrieval, and elution of capsid-associated cellular proteins. Proteins will be identified by state of the art mass
spectrometry methods and prioritized for further study based on statistical and bioinformatics analyses of
samples and controls, and on protein cellular locations, pathways, and functions.
2. Define the role of host proteins in alphavirus exit. We will test a prioritized set of candidate host
proteins for roles in the alphavirus exit pathway. Host proteins will be depleted by siRNA targeting and effects
on alphavirus primary infection and virus production determined. Proteins showing the most specific effects on
alphavirus exit will be further characterized in knock-out and overexpressing cells using our established battery
of assays for defined steps in virus exit.
The results of these studies will provide fundamental information on host proteins that affect alphavirus
assembly and budding, and potential new targets for antiviral strategies.
甲病毒包括重要的和新出现的人类病原体,如脑炎病毒和甲型h1n1流感病毒
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET KIELIAN其他文献
MARGARET KIELIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET KIELIAN', 18)}}的其他基金
Project 6 - Development of Antivirals against Alphaviruses
项目 6 - 开发抗甲病毒的抗病毒药物
- 批准号:
10513947 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Identification and characterization of host proteins involved in the alphavirus exit pathway
甲病毒退出途径中宿主蛋白的鉴定和表征
- 批准号:
10352876 - 财政年份:2021
- 资助金额:
$ 21万 - 项目类别:
Mechanism and inhibition of dengue and chikungunya virus fusion protiens
登革热和基孔肯雅病毒融合蛋白的作用机制及抑制作用
- 批准号:
8230243 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Mechanism and inhibition of dengue and chikungunya virus fusion protiens
登革热和基孔肯雅病毒融合蛋白的作用机制及抑制作用
- 批准号:
7670803 - 财政年份:2009
- 资助金额:
$ 21万 - 项目类别:
Molecular Analysis of Alphavirus Membrane Fusion Protein
甲病毒膜融合蛋白的分子分析
- 批准号:
7919163 - 财政年份:2009
- 资助金额:
$ 21万 - 项目类别:
Inhibition of the Membrane Fusion Proteins of Flaviviruses and Alphaviruses
黄病毒和甲病毒膜融合蛋白的抑制
- 批准号:
7255226 - 财政年份:2007
- 资助金额:
$ 21万 - 项目类别:
Inhibition of the Membrane Fusion Proteins of Flaviviruses and Alphaviruses
黄病毒和甲病毒膜融合蛋白的抑制
- 批准号:
7414889 - 财政年份:2007
- 资助金额:
$ 21万 - 项目类别:
相似海外基金
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
- 批准号:
10727819 - 财政年份:2023
- 资助金额:
$ 21万 - 项目类别:
Elucidating the mechanisms of alphavirus subgenomic RNA translation
阐明甲病毒亚基因组 RNA 翻译机制
- 批准号:
10678281 - 财政年份:2023
- 资助金额:
$ 21万 - 项目类别:
Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine
交叉保护性新世界脑炎甲病毒亚单位疫苗的研制
- 批准号:
10696914 - 财政年份:2023
- 资助金额:
$ 21万 - 项目类别:
Defining the Molecular Determinants of Encephalitic Alphavirus Viremia
定义脑炎甲病毒血症的分子决定因素
- 批准号:
10599124 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Defining the Molecular Determinants of Encephalitic Alphavirus Viremia
定义脑炎甲病毒血症的分子决定因素
- 批准号:
10384551 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10631703 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1
甲病毒感染性和适应机制 - 重新提交 - 1
- 批准号:
10556424 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Structural Mechanisms of Alphavirus Membrane Fusion
甲病毒膜融合的结构机制
- 批准号:
10444088 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Structural Mechanisms of Alphavirus Membrane Fusion
甲病毒膜融合的结构机制
- 批准号:
10612929 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1
甲病毒感染性和适应机制 - 重新提交 - 1
- 批准号:
10444392 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:














{{item.name}}会员




